Lanzotyle DX 60 Capsules contain Dexlansoprazole 60mg, a next-generation proton pump inhibitor (PPI) designed for effective and prolonged suppression of gastric acid secretion. Its dual delayed-release technology ensures sustained acid control throughout the day and night.
Dexlansoprazole works by inhibiting the H⁺/K⁺-ATPase enzyme system in gastric parietal cells, helping to heal erosive esophagitis, reduce heartburn, and prevent acid reflux recurrence with once-daily dosing.
From a commercial viewpoint, Lanzotyle DX 60 Capsules are a high-demand gastroenterology product, widely prescribed by physicians and gastroenterologists, ensuring strong repeat prescriptions and consistent market movement.
Adding Lanzotyle DX 60 Capsules to your portfolio strengthens the gastrointestinal and acid-suppression segment, offering long-term growth, high prescriber acceptance, and reliable returns for PCD pharma franchise partners.
Common side effects may include headache, diarrhea, abdominal pain, nausea, or flatulence. Rarely, dizziness, skin rash, or vitamin and mineral deficiencies may occur with long-term use.
Lanzotyle DX 60 Capsule is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, and conditions associated with excessive stomach acid production. It is also used for maintenance therapy to prevent relapse of acid-related disorders under medical supervision.
Use Lanzotyle DX 60 Capsule strictly as prescribed by a physician. Do not crush or chew the capsule; swallow it whole. Prolonged use should be monitored by a healthcare professional. Consult a doctor immediately if severe stomach pain, persistent diarrhea, or allergic reactions occur.
Store in a cool, dry place below 25 °C. Protect from moisture and direct sunlight. Keep the capsules in their original packaging and out of reach of children. Do not use after the expiry date.